Terms: = Liver cancer AND TNFRSF17, BCMA, 608, ENSG00000048462, CD269, Q02223, BCM AND Prognosis
28 results:
1. Hepatitis B surface antigen positivity is associated with poor short- and long-term outcomes in patients with diffuse large B-cell lymphoma who received CHOP or R-CHOP.
Zhan Z; Guo W; Wan X; Wang B; Li J; Wang H; Li Z; Huang Y; Young KH; Bai O
Front Immunol; 2024; 15():1324113. PubMed ID: 38318173
[TBL] [Abstract] [Full Text] [Related]
2. Prognostic significance of pretreatment albumin-bilirubin (ALBI) grade and platelet-albumin-bilirubin (PALBI) grade in patients with small cell lung cancer.
Kut E; Menekse S
Sci Rep; 2024 Jan; 14(1):1371. PubMed ID: 38228667
[TBL] [Abstract] [Full Text] [Related]
3. Predicting glypican-3 expression in hepatocellular carcinoma: A comprehensive analysis using combined contrast-enhanced ultrasound and clinical factors.
Li N; Dong T; Wang P; Li Q; Nie F
Clin Hemorheol Microcirc; 2023; 85(4):407-420. PubMed ID: 37638421
[TBL] [Abstract] [Full Text] [Related]
4. Novel models by machine learning to predict prognosis of breast cancer brain metastases.
Li C; Liu M; Zhang Y; Wang Y; Li J; Sun S; Liu X; Wu H; Feng C; Yao P; Jia Y; Zhang Y; Wei X; Wu F; Du C; Zhao X; Zhang S; Qu J
J Transl Med; 2023 Jun; 21(1):404. PubMed ID: 37344847
[TBL] [Abstract] [Full Text] [Related]
5. Belantamab in Combination with Dexamethasone in Patients with Triple-class Relapsed/Refractory Multiple Myeloma.
Atieh T; Atrash S; Ahmed N; Mohan M; Cui W; Shune L; Hajjar S; Mahmoudjafari Z; Quick J; Wishna A; Riffel J; McGuirk J; Mohyuddin GR; Abdallah AO
Clin Lymphoma Myeloma Leuk; 2022 Dec; 22(12):912-919. PubMed ID: 36127271
[TBL] [Abstract] [Full Text] [Related]
6. Factors affecting prognosis in hepatocellular carcinoma patients post-transarterial chemoembolization.
Prateepchaiboon T; Chang A; Pungpipattrakul N; Akarapatima K; Rattanasupar A; Songjamrat A; Pakdeejit S; Piratvisuth T
Indian J Gastroenterol; 2022 Aug; 41(4):352-361. PubMed ID: 36029371
[TBL] [Abstract] [Full Text] [Related]
7. CT-based skeletal muscle loss for predicting poor survival in patients with hepatocellular carcinoma experiencing curative hepatectomy plus adjuvant transarterial chemoembolization: a preliminary retrospective study.
Yang S; Zhang Z; Su T; Yu J; Cao S; Wang H; Jin L
Eur J Med Res; 2022 Jul; 27(1):131. PubMed ID: 35879734
[TBL] [Abstract] [Full Text] [Related]
8. The C-Reactive Protein to Albumin Ratio Is an Independent Prognostic Factor in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization: A Large Cohort Study.
Li J; Yang S; Li Y; Li C; Xia Y; Zhu S; Xia J
Cardiovasc Intervent Radiol; 2022 Sep; 45(9):1295-1303. PubMed ID: 35835873
[TBL] [Abstract] [Full Text] [Related]
9. Consensus subtypes of hepatocellular carcinoma associated with clinical outcomes and genomic phenotypes.
Lee SH; Yim SY; Jeong YS; Li QX; Kang SH; Sohn BH; Kumar SV; Shin JH; Choi YR; Shim JJ; Kim H; Kim JH; Kim S; Guo S; Johnson RL; Kaseb A; Kang KJ; Chun YS; Jang HJ; Lee BG; Woo HG; Ha MJ; Akbani R; Roberts LR; Wheeler DA; Lee JS
Hepatology; 2022 Dec; 76(6):1634-1648. PubMed ID: 35349735
[TBL] [Abstract] [Full Text] [Related]
10. The Significance of Surgical Intervention for Metasynchronous liver Metastasis in Gastric cancer: A Single-centre Analysis.
Hanaki T; Sunaguchi T; Goto K; Morimoto M; Murakami Y; Shishido Y; Miyatani K; Kihara K; Matsunaga T; Yamamoto M; Tokuyasu N; Sakamoto T; Hasegawa T; Fujiwara Y
Anticancer Res; 2022 Apr; 42(4):2177-2184. PubMed ID: 35347042
[TBL] [Abstract] [Full Text] [Related]
11. Clinical features and outcomes of combined hepatocellular carcinoma and cholangiocarcinoma versus hepatocellular carcinoma versus cholangiocarcinoma after surgical resection: a propensity score matching analysis.
Lin CW; Wu TC; Lin HY; Hung CM; Hsieh PM; Yeh JH; Hsiao P; Huang YL; Li YC; Wang YC; Shu CW; Chen YS
BMC Gastroenterol; 2021 Jan; 21(1):20. PubMed ID: 33413162
[TBL] [Abstract] [Full Text] [Related]
12. Survival and prognostic analysis of preoperative indicators in patients undergoing surgical resections with rhabdomyosarcoma.
Jin H; Zhang M; Zhou H; Zhu S; Hu C
Medicine (Baltimore); 2020 Oct; 99(43):e22760. PubMed ID: 33120782
[TBL] [Abstract] [Full Text] [Related]
13. TP53 R249S mutation detected in circulating tumour DNA is associated with prognosis of hepatocellular carcinoma patients with or without hepatectomy.
Shen T; Li SF; Wang JL; Zhang T; Zhang S; Chen HT; Xiao QY; Ren WH; Liu C; Peng B; Ji XN; Yang Y; Lu PX; Chen TY; Yu L; Ji Y; Jiang DK
Liver Int; 2020 Nov; 40(11):2834-2847. PubMed ID: 32594568
[TBL] [Abstract] [Full Text] [Related]
14. Nomograms to predict the long-time prognosis in patients with alpha-fetoprotein negative hepatocellular carcinoma following radical resection.
Huang J; Liu FC; Li L; Zhou WP; Jiang BG; Pan ZY
Cancer Med; 2020 Apr; 9(8):2791-2802. PubMed ID: 32096346
[TBL] [Abstract] [Full Text] [Related]
15. Daily decrease of post-operative alpha-fetoprotein by 9% discriminates prognosis of HCC: A multicenter retrospective study.
Zhou PY; Yang CP; Tang Z; Yi Y; Liu WR; Tian MX; Huang JL; Gan W; Jiang XF; Liu G; Wang H; Tao CY; Fang Y; Qu WF; Zhou C; Guan RY; Sun BY; Zhou YF; Song SS; Ding ZB; Peng YF; Dai Z; Zhou J; Fan J; Gong GZ; Shi YH; Qiu SJ
Aging (Albany NY); 2019 Dec; 11(23):11111-11123. PubMed ID: 31829979
[TBL] [Abstract] [Full Text] [Related]
16. Integrated analysis of clinical significance and functional involvement of microRNAs in hepatocellular carcinoma.
Qin L; Huang J; Wang G; Huang J; Wu X; Li J; Yi W; Qin F; Huang D
J Cell Physiol; 2019 Dec; 234(12):23581-23595. PubMed ID: 31210353
[TBL] [Abstract] [Full Text] [Related]
17. Albumin-bilirubin grade may determine the outcomes of patients with very early stage hepatocellular carcinoma after radiofrequency ablation therapy.
Chen PC; Chiu NC; Su CW; Huang YH; Hou MC; Lin HC; Wu JC
J Chin Med Assoc; 2019 Jan; 82(1):2-10. PubMed ID: 30839396
[TBL] [Abstract] [Full Text] [Related]
18. Evaluation of CT vascularization patterns for survival prognosis in patients with hepatocellular carcinoma treated by conventional TACE.
Hasdemir DB; Dávila LA; Schweitzer N; Meyer BC; Koch A; Vogel A; Wacker F; Rodt T
Diagn Interv Radiol; 2017; 23(3):217-222. PubMed ID: 28256449
[TBL] [Abstract] [Full Text] [Related]
19. Patterns of sorafenib and TACE treatment of unresectable hepatocellular carcinoma in a Chinese population: subgroup analysis of the GIDEON study.
Liu F; Meng Z; Shao G; Wang J; Wang Z; Yang J; Yip CS; He D
Mol Biol Rep; 2017 Feb; 44(1):149-158. PubMed ID: 27981445
[TBL] [Abstract] [Full Text] [Related]
20. MiR-608 rs4919510 is associated with prognosis of hepatocellular carcinoma.
Ma XP; Yu G; Chen X; Xiao Q; Shi Z; Zhang LY; Chen H; Zhang P; Ding DL; Huang HX; Saiyin H; Chen TY; Lu PX; Wang NJ; Yu H; Conran C; Sun J; Zheng SL; Xu J; Yu L; Jiang DK
Tumour Biol; 2016 Jul; 37(7):9931-42. PubMed ID: 26815502
[TBL] [Abstract] [Full Text] [Related]
[Next]
